Nanoparticles comprising antigens and adjuvants, and immunogenic structures
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 14, 2015
Grant Date -
Apr 23, 2009
app pub date -
Sep 30, 2005
filing date -
Oct 1, 2004
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Nanoparticles comprising adjuvants and antigens, such as tumor and pathogen antigens, are disclosed and their use in a range of applications such as for the treatment of cancer and infectious diseases. Immunogenic structures based on nanoparticles or antibodies with carbohydrate ligands, and their use for therapeutic and prophylactic purposes, and for the isolation and detection of antibodies directed against the carbohydrate structures.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully